Publications by authors named "Llorenc Font"

Claim this Profile
V
Ventilation/perfusion (V/Q) scanning in contemporary patients with pulmonary embolism: utilization rates and predictors of use in a multinational study.
Pierre-Benoît Bonnefoy, Nathalie Prevot, Ghazaleh Mehdipoor, Alicia Sanchez, Jorge Lima, Llorenç Font

J Thromb Thrombolysis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning to Predict Outcomes in Patients with Acute Pulmonary Embolism Who Prematurely Discontinued Anticoagulant Therapy.
Damián Mora, José A Nieto, Jorge Mateo, Behnood Bikdeli, Stefano Barco, Llorenç Font

Thromb Haemost· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study.
Marc Blondon, David Jimenez, Helia Robert-Ebadi, Jorge Del Toro, Luciano Lopez-Jimenez, Llorenç Font

J Thromb Haemost· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database.
Harry E Fuentes, Alfonso J Tafur, Joseph A Caprini, Adriano Alatri, Javier Trujillo-Santos, Llorenç Font

Int Angiol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.
Vicent Guillem, Marisa Calabuig, Salut Brunet, Jordi Esteve, Lourdes Escoda, Llorenç Font

Leuk Lymphoma· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Adriano Alatri, Lucia Mazzolai, Carme Font, Alfonso Tafur, Reina Valle, Llorenç Font

Thromb Haemost· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical usefulness of fluorescence in situ hybridization for detection of MLL rearrangements in acute myeloid leukemia.
Neus Ruiz-Xivillé, Isabel Granada, Diana Campos, Adela Cisneros, Javier Grau, Llorenç Font

Leuk Lymphoma· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
Jose Portillo, Iris Violeta de la Rocha, Llorenç Font, Andrei Braester, Olga Madridano

Thromb Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry.
Chiara Piovella, Fabio Dalla Valle, Javier Trujillo-Santos, Raffaele Pesavento, Leonor López, Llorenç Font

Intern Emerg Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
Blanca Espinet, Itziar Salaverria, Sílvia Beà, Neus Ruiz-Xivillé, Olga Balagué, Llorenç Font

Genes Chromosomes Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute liver failure as the first manifestation of very late relapsing of Hodgkin's disease.
Xavier Ortín, Marta Rodríguez-Luaces, Ramon Bosch, Marylene Lejeune, Llorenç Font

Hematol Rep· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stroke in a multiple myeloma patient treated with thalidomide.
Xavier Ortín, Marta Rodríguez-Luaces, Marisa Calabuig, Llorenç Font

J Stroke Cerebrovasc Dis· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
Francesc Bosch, Ana Ferrer, Neus Villamor, Marcos González, Javier Briones, Llorenç Font

Clin Cancer Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.
Joan Bladé, Laura Rosiñol, Ana Sureda, Josep M Ribera, Joaquín Díaz-Mediavilla, Llorenç Font, Montserrat Fontanillas

Blood· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Disseminated cytomegalovirus infection in a patient with peripheral T cell unspecified (variant-Lennert) non-Hodgkin lymphoma].
Xavier Ortín, Marta Rodríguez-Luaces, Ramón Bosch, Llorenç Font

Med Clin (Barc)· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis